The next installment of the ICR Healthcare Conference Series will focus on the evolving development of treatments for Antibody-Drug Conjugates.

Discussion topics will include:

• The giant leaps in innovation being made in the field and how they will impact the market
• How ADC therapies are overcoming the challenges of the past
• Assessing Big Pharma's appetite for the field
• Looking 10 years ahead: The future landscape of ADC therapies

SPEAKERS  - Click name for bio